Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness
- PMID: 19117750
- DOI: 10.1016/j.ejca.2008.11.032
Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness
Abstract
The value of the modern cancer registry and its ability to carry out cancer control activities rely heavily on the underlying quality of its data and the quality control procedures in place. This two-part review provides an update of the practical aspects and techniques for addressing data quality at the cancer registry. This first installment of the review examines the factors influencing three of the four key aspects, namely, the comparability, validity and timeliness of cancer registry data. Comparability of cancer data may be established through a comprehensive review of the registration routines in place. Validity is examined via numerical indices of that permit comparisons with other registries, or, within a registry, over time, or with respect to specified subsets of cases. There are no international guidelines for timeliness at present, although specific standards for the abstraction and reporting of registry have been set out by certain organisations.
Similar articles
-
Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness.Eur J Cancer. 2009 Mar;45(5):756-64. doi: 10.1016/j.ejca.2008.11.033. Epub 2009 Jan 6. Eur J Cancer. 2009. PMID: 19128954 Review.
-
Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness.Acta Oncol. 2012 Sep;51(7):880-9. doi: 10.3109/0284186X.2012.698751. Acta Oncol. 2012. PMID: 22974093
-
The Danish Cancer Registry--history, content, quality and use.Dan Med Bull. 1997 Nov;44(5):535-9. Dan Med Bull. 1997. PMID: 9408738
-
Comparability of colorectal cancer survival data in three European population-based registries.Eur J Cancer Prev. 1998 Apr;7(2):127-34. Eur J Cancer Prev. 1998. PMID: 9818774
-
Quality, comparability and methods of analysis of data on childhood cancer in Europe (1978-1997): report from the Automated Childhood Cancer Information System project.Eur J Cancer. 2006 Sep;42(13):1915-51. doi: 10.1016/j.ejca.2006.05.007. Eur J Cancer. 2006. PMID: 16919762 Review.
Cited by
-
The Importance of Training and Assessing Quality Control Reviewers in Technology-Enabled Abstraction of Real-World Data: A Case Study.J Registry Manag. 2024 Summer;51(2):81-86. J Registry Manag. 2024. PMID: 39184215 Free PMC article.
-
A Validation of the Swedish Colorectal Cancer Register - With Focus on Histopathology, Complications and Recurrences.Clin Epidemiol. 2024 Aug 9;16:525-532. doi: 10.2147/CLEP.S466029. eCollection 2024. Clin Epidemiol. 2024. PMID: 39139476 Free PMC article.
-
[Estimation of cancer incidence in Brazil and its regions in 2018: methodological aspects].Cad Saude Publica. 2024 Jul 29;40(6):e00131623. doi: 10.1590/0102-311XPT131623. eCollection 2024. Cad Saude Publica. 2024. PMID: 39082568 Free PMC article. Portuguese.
-
Cancer incidence and mortality in China, 2015.J Natl Cancer Cent. 2020 Dec 17;1(1):2-11. doi: 10.1016/j.jncc.2020.12.001. eCollection 2021 Mar. J Natl Cancer Cent. 2020. PMID: 39036787 Free PMC article.
-
Lung cancer incidence and mortality in China: Updated statistics and an overview of temporal trends from 2000 to 2016.J Natl Cancer Cent. 2022 Jul 30;2(3):139-147. doi: 10.1016/j.jncc.2022.07.004. eCollection 2022 Sep. J Natl Cancer Cent. 2022. PMID: 39036448 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
